Invention Grant
- Patent Title: Method of treating VEGF/VEGFR resistant prostate cancer by combining the therapy with RAC1 inhibitors
-
Application No.: US16076981Application Date: 2017-02-16
-
Publication No.: US10947537B2Publication Date: 2021-03-16
- Inventor: Hira Lal Goel , Arthur M. Mercurio
- Applicant: University of Massachusetts
- Applicant Address: US MA Boston
- Assignee: University of Massachusetts
- Current Assignee: University of Massachusetts
- Current Assignee Address: US MA Boston
- Agency: Fish & Richardson P.C.
- International Application: PCT/US2017/018179 WO 20170216
- International Announcement: WO2017/143070 WO 20170824
- Main IPC: C12N15/113
- IPC: C12N15/113 ; C07K14/00 ; C07K16/22 ; C07K14/47 ; A61K31/506 ; A61K31/404 ; A61P35/00 ; A61K31/7088 ; A61K39/395
Abstract:
Methods and compositions for treating cancer, e.g., prostate cancer, using a combination of P-Rex1 or Rac1 inhibitors and VEGF/VEGFR-targeted therapy.
Public/Granted literature
- US20190040396A1 Combination Therapy Public/Granted day:2019-02-07
Information query
IPC分类:
